Disease block
D10-D36 – Gutartige Neubildungen
- Chapter II: Neubildungen
8Decisions
10Patient groups
Added benefit by patient group
- Major1
- Considerable1
- Minor1
- Non-quantifiable5
- Not proven2
Diseases in this disease block
Decisions, newest first
Each decision lists only the patient groups coded with a disease in this disease block.
- 2026-08-06KoselugoSelumetinibNon-quantifiable
- 2026-05-07KoselugoSelumetinibMinor
- 2026-05-07KoselugoSelumetinibNon-quantifiable
- 2026-03-19EzmeklyMirdametinibNon-quantifiable
- 2025-03-06YseltyLinzagolixNot proven
- 2024-03-21HyftorSirolimusNon-quantifiable
- 2022-02-17RyeqoRelugolix/Estradiol/NorethisteronConsiderable: 1 of 2 patient groupsNot proven: 1 of 2 patient groups
- 2015-02-19HemangiolPropranololMajor: 1 of 2 patient groupsNon-quantifiable: 1 of 2 patient groups
Data status: 2026-10-29